A large diversity of 2-aminoimidazolone alkaloids is produced by various marine invertebrates, especially by the marine Calcareous sponges Leucetta and Clathrina. The phylogeny of these sponges and the wide scope of 2-aminoimidazolone alkaloids they produce are reviewed in this article. The origin (invertebrate cells, associated microorganisms, or filtered plankton), physiological functions, and natural molecular targets of these alkaloids are largely unknown. Following the identification of leucettamine B as an inhibitor of selected protein kinases, we synthesized a family of analogues, collectively named leucettines, as potent inhibitors of DYRKs (dual-specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) and potential pharmacological leads for the treatment of several diseases, including Alzheimer’s disease and Down syndrome. We assembled a small library of marine sponge- and ascidian-derived 2-aminoimidazolone alkaloids, along with several synthetic analogues, and tested them on a panel of mammalian and protozoan kinases. Polyandrocarpamines A and B were found to be potent and selective inhibitors of DYRKs and CLKs. They inhibited cyclin D1 phosphorylation on a DYRK1A phosphosite in cultured cells. 2-Aminoimidazolones thus represent a promising chemical scaffold for the design of potential therapeutic drug candidates acting as specific inhibitors of disease-relevant kinases, and possibly other disease-relevant targets.
deltif Amrane, et al.. Assessment of VOC absorption in hydrophobic ionic liquids: Measurement of partition and diffusion coefficients and simulation of a packed column. Chemical Engineering Journal, Elsevier, 2019, 360, pp. AbstractPartition coefficients of toluene and dichloromethane (DCM) in 23 hydrophobic ionic liquids (ILs), which can be used potentially for the physical absorption of volatile organic compounds (VOCs), were measured at 298 K. The partition coefficients, expressed as Henry's law constants, were 400 to 1300 times for toluene and 10 to 47 times for DCM lower in the selected ILs than in water. Thus, the toluene and DCM diffusion coefficients were measured in three high potential hydrophobic ILs and in [Bmim][NTf 2 ] using a thermogravimetric microbalance. Diffusivity measurements were performed at 298K for toluene and between 278 and 308K for DCM. Diffusion coefficients in ILs, ranging between 1 and 4×10 -11 m 2 s -1 , were from 18 to 90 times lower than in water at 298 K. The diffusion coefficients were correlated to the temperature, the solute molar volume, the IL viscosity and molar volume with an average error of 4.2%. Finally, a 3 m industrial packed column was simulated for the removal of DCM and toluene in [AllylEt 2 S][NTf 2 ] and [bmim][NTf 2 ], which both present moderate viscosities of nearly 50 mPa s at 293K. The overall mass-transfer coefficient, the removal efficiency and the pressure drop were calculated and compared to those obtained using other heavy solvents (a silicon * Corresponding author : pierre-francois.biard@ensc-rennes.fr, Tel: + 33 2 23 23 81 49 2 oil and di-(2-ethylhexyl) adipate). This prospective simulation has demonstrated a good potential of ionic liquids for the toluene removal. Nonetheless, the DCM removal efficiencies simulated were lower than 44%. It suggests that even more efficient ionic liquids can be tuned and synthesized in the future for this specific application. Highlights Toluene partition coefficients in 23 ILs were in the range 0.5-3.5 Pa m 3 mol -1 Dichloromethane partition coefficients in 23 ILs were in the range 5-17 Pa m 3 mol -1 VOC diffusion coefficients in the range 1-4×10 -11 m 2 s -1 were measured in 4 ILs The computed toluene removal efficiency in a packed column was from 52 to 99.6% The computed dichloromethane removal efficiency in a packed column was lower than 44% Graphical abstractVicious air containing VOC: Treated air Ionic liquid Loaded ionic liquid Metal Pall rings 3.0 m 1.0 m •Toluene •Dichloromethane Operating conditions Hydrodynamics Mass-transfer rate (K l a°) Pressure drop Removal efficiency Solvent assessment for VOC removal in a packed column Partition coefficient Diffusion coefficient Ionic liquid properties (m, r, s) Static headspace method Static thermogravimetric method Measurements Simulation •[bmim][NTf 2 ] •[AllylEt 2 S][NTf 2 ] Finally, the hydrodynamics and mass-transfer in a packed column fed with [Bmim][NTf 2 ] and [AllylEt 2 S][NTf 2 ] were simulated for DCM and toluene absorption. * AR is the affinity r...
The protein kinase DYRK1A is involved in Alzheimer’s disease, Down syndrome, diabetes, viral infections, and leukemia. Leucettines, a family of 2-aminoimidazolin-4-ones derived from the marine sponge alkaloid Leucettamine B, have been developed as pharmacological inhibitors of DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases). We report here on the synthesis and structure–activity relationship (SAR) of 68 Leucettines. Leucettines were tested on 11 purified kinases and in 5 cellular assays: (1) CLK1 pre-mRNA splicing, (2) Threonine-212-Tau phosphorylation, (3) glutamate-induced cell death, (4) autophagy and (5) antagonism of ligand-activated cannabinoid receptor CB1. The Leucettine SAR observed for DYRK1A is essentially identical for CLK1, CLK4, DYRK1B, and DYRK2. DYRK3 and CLK3 are less sensitive to Leucettines. In contrast, the cellular SAR highlights correlations between inhibition of specific kinase targets and some but not all cellular effects. Leucettines deserve further development as potential therapeutics against various diseases on the basis of their molecular targets and cellular effects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.